Expiratory central airway collapse associated with poor quality of life
1. Expiratory central airway collapse is associated with chronic obstructive pulmonary disease and a poorer quality of life. 2. However, ...
Tag: copd
COPD patients show substantial variation in lifetime rate of decline
1. The reigning paradigm of COPD pathogenesis is that there is an accelerated decline in forced expiratory volume in 1 second ...
Double-lung transplantation associated with lower mortality in IPF
1. Double-lung transplant is associated with lower 5-year mortality rates than single-lung transplant in patients with idiopathic pulmonary fibrosis (IPF). ...
Healthier diets linked with lower risk of COPD in both smokers and nonsmokers
1. Individuals with the healthiest overall diets according to the Alternate Health Eating Index 2010 (AHEI-2010) had the lowest risk ...
Non-invasive ventilation linked with lower mortality in COPD exacerbations
1. For patients admitted with chronic obstructive pulmonary disease (COPD) exacerbations requiring ventilatory support, non-invasive ventilation (NIV) was associated with ...
Improved COPD outcomes with combined long-acting beta-agonist and inhaled steroid therapy
1. Compared to the use of long-acting β-agonists (LABAs) alone, combination therapy with LABAs and inhaled steroids resulted in a ...
![Combo angiotensin-neprilysin inhibitor superior to enalapril in heart failure [PARADIGM-HF trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Angiotensin-350x250.jpg)
2 Minute Medicine Rewind September 8 – September 14, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Angiotensin–Neprilysin ...
Paradoxical response to beta-2 agonists found in African-Americans, linked to morbidity
1. A paradoxical response to beta-2 (β2)-agonists (causing bronchoconstriction rather than bronchodilation) was seen in 5% of former and current ...
Benralizumab does not reduce the rate of acute COPD exacerbations
1. Patients treated with benralizumab did not experience a reduced annual rate of acute COPD exacerbations. 2. However, benralizumab treatment ...
The TORCH trial: Combination of salmeterol and fluticasone in treating COPD [Classics Series]
1. The combination of salmeterol and fluticasone did not significantly reduce all-cause mortality in patients with chronic pulmonary obstructive disease ...
